Wellcome Sanger Institute
Collaboration
Human Genetics

Genomics England

Genomics England is a company wholly owned by the UK government, tasked with delivering genomic medicine in partnership with the NHS. Genomics England delivered the 100,000 genomes project, with a focus on whole genome sequencing of patients with rare diseases or cancer.

About the Sanger Institute's work with Genomics England

The Genomics England sequencing facility is situated on the Genome Campus. Genomic England partners with the Sanger Institute on Research and Development, with a particular focus on new sequencing technologies and informatics. Genomics England is advancing scientific discoveries by consenting NHS patients for research and making these data available to the research community to drive improvements in genomic medicine. Genomics England is a key partner for the Human Genetics programme in delivering research insights in the genetic causes of developmental disorders.

Contact

If you need help or have any queries, please contact us using the details below.

Email: meh@sanger.ac.uk

Sanger people

Photo of Professor Matthew Hurles

Professor Matthew Hurles

Director the Wellcome Sanger Institute and Senior Group Leader

Related groups

 

Science group

Hurles Group

Genomic mutation and genetic disease

The Hurles group studies the genetic causes and mechanisms of rare genetic disorders and how DNA mutates as it is pass ...
 
Wellcome Sanger Institute

Programmes and Facilities

 

Programme

Human Genetics

The Human Genetics Programme is driving a step-change in our understanding of genetic causes and biological mechanisms of disease susceptibility and ...